Centiva Capital’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-254,400
Closed -$3.03M – 2175
2026
Q1
$3.03M Sell
254,400
-34,000
-12% -$488K 0.02% 350
2025
Q4
$4.46M Buy
+288,400
New +$5.3M 0.04% 282
2025
Q2
– Sell
-40,000
Closed -$950K – 1995
2025
Q1
$950K Buy
+40,000
New +$947K 0.03% 528

Other funds holding SGRY

Centiva Capital's SGRY Position: Q2 2026 in Review

Centiva Capital reduced its Surgery Partners (SGRY) stake by 98% in Q2 2026, selling an estimated $2.9M and leaving 5,000 shares worth $84K. The position accounts for ﹤0.01% of the portfolio, ranked #1547.

Centiva Capital first reported a position in SGRY in Q2 2023 and has held it in 10 quarters since. The position peaked at $2.52M in Q1 2026. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • Centiva Capital held 5,000 shares of Surgery Partners worth $84K as of Q2 2026.
  • Centiva Capital sold 206,299 Surgery Partners shares in Q2 2026, an estimated $2.9M.
  • Surgery Partners made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1547 holding.
  • Centiva Capital first reported a position in Surgery Partners in Q2 2023 and has held it in 10 quarters since.
  • Centiva Capital's Surgery Partners position peaked at $2.52M in Q1 2026.
  • 187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.